trending Market Intelligence /marketintelligence/en/news-insights/trending/XZiUuBaBus8rBspWQsmb4w2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

KKR completes $1.4B acquisition of PharMerica

Street Talk Episode 68 - As many investors zig away from bank stocks, 2 vets in the space zag toward them

Street Talk Episode 66 - Community banks tap the debt markets while the getting is good

Street Talk Episode 67 - Veteran investor tabs Mick Mulvaney to help with latest financial stock-focused fund

Street Talk Episode 65 - Deferral practices trap US bank portfolios in purgatory

KKR completes $1.4B acquisition of PharMerica

KKR & Co. LP completed the $1.4 billion acquisition of PharMerica Corp. via a newly formed company that counts drugstore chain Walgreens Boots Alliance Inc. as a minority investor.

PharMerica shareholders will receive $29.25 per share in cash from KKR.

The acquisition takes PharMerica private and its shares will cease trading on the NYSE before the markets opens Dec. 8.

In November, stockholders of PharMerica, a provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, approved the takeover of the company.

UBS Investment Bank and Bank of America Merrill Lynch are serving as financial advisers to PharMerica and Davis Polk & Wardwell LLP is serving as the company's legal adviser.

Simpson Thacher & Bartlett LLP and Weil Gotshal & Manges LLP are serving as legal advisers to KKR and Walgreens Boots Alliance, respectively.